Prenatal and Newborn Genetic Testing Market Share, Size, and Outlook by 2031
Prenatal and Newborn Genetic Testing Market: Size and Share
-
CAGR (2023 - 2031)14.5% -
Market Size 2021
US$ 5.72 Billion -
Market Size 2031
US$ 21.44 Billion
Market Dynamics
- High Prevalence of Genetic Diseases in Infants
- Government Support to Encourage Prenatal and Newborn Testing
- Digital Microfluidics Poses a New Trend for the Newborn Screening
Market Segmentation
- Diagnostic
- Screening
- Cystic Fibrosis
- Sickle Cell Anaemia
- Down Syndrome
- Phenylketonuria
- Other Diseases
- Hospitals & Clinics
- Diagnostic Centers
- Other End Users
Prenatal and Newborn Genetic Testing Market Players Density: Understanding Its Impact on Business Dynamics
The Prenatal and Newborn Genetic Testing Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Prenatal and Newborn Genetic Testing Market are:
- Abbott
- Quest Diagnostics Inc.
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- F. Hoffmann La-Roche Ltd.
- Qiagen
Disclaimer: The companies listed above are not ranked in any particular order.
- Get the Prenatal and Newborn Genetic Testing Market top key players overview